Scanning micro-cantilever based catheter for in vivo imaging

支气管镜是一种细长的仪器，可以通过鼻子或嘴巴插入，用于显示 航空公司。支气管镜通常由装有光纤系统的中空管组成，光纤系统从支气管端传输图像 将仪器的另一端的摄像机。 该项目建议开发一种超微型导管，以便访问和可视化最小的肺气道 不需要开胸手术。该项目源于申请者开发的新技术。这个 研究将集中在开发超微型导管，并使用动物模型评估其性能。 这项拟议的研究有可能极大地降低医疗保健成本和因肺部疾病造成的生产力损失。 通过早期准确的诊断和后续治疗。大量人口将潜在地受益于拟议的 技术关于肺癌，2012年加拿大癌症统计报告称，超过四分之一(27%)的癌症 死亡被归因于肺癌。2012年，估计有2.56万加拿大人被诊断出患有肺癌。 合作对项目的成功至关重要，研究团队将工程师、医学科学家聚集在一起 和医生，以及医疗器械行业。不列颠哥伦比亚省癌症机构将是该项目的关键合作伙伴，提供指导 在技术开发过程中，确保该设计适合广泛的临床应用。一家工业企业 合作伙伴Novadaq将提供市场和商业化观点，并将采用由此产生的技术。 由于需要通过这两个设计进行密切合作，知识传递和交叉受精将自然发生 和测试阶段。所有合作伙伴都将参与学生的跨学科培训。高科技、跨学科 该项目对加拿大的研究生实习生来说是一个绝佳的研究机会。

Bronchoscopes are thin and long instruments that are inserted through either the nose or mouth and used to visualize the airways. Bronchoscopes generally consist of a hollow tube housing a fiber optic system that transmits an image from the tip of the instrument to a video camera at the opposite end. This project proposes to develop an ultra-miniaturized catheter in order to access and visualise the smallest lung airways without the need of open surgery. This project arises from novel technology that has been developed by the applicants. The research will focus on developing the ultra-miniaturized catheter and assessing its performance using an animal model. The proposed research has the potential to greatly reduce health care costs and losses in productivity due to lung diseases through early and accurate diagnosis and subsequent treatment. A large population will potentially benefit from the proposed technology. With regards to lung cancer, Canadian Cancer Statistics 2012 reports that over one-quarter (27%) of all cancer deaths were attributed to lung cancer. In 2012, 25,600 Canadians were estimated to be diagnosed with lung cancer. Collaboration is essential to the success of the project and the research team brings together engineers, medical scientists and doctors, and the medical device industry. The BC Cancer Agency will be a key partner in this project, providing guidance during the development of the technology to ensure the design is appropriate for widespread clinical use. An industrial partner, Novadaq, will provide the market and commercialization perspective and will adopt the resulting technology. Knowledge transfer and cross-fertilization will occur naturally due to the need for close collaboration through both the design and test phases. All partners will participate in the interdisciplinary training of students. The high-tech, interdisciplinary project represents an outstanding research opportunity for graduate trainees in Canada.